The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.
Tropicana recently ditched its distinct orange juice in clear, plastic circular-shaped bottles with a thinning neck and a ...
The National Institute for Health and Care Excellence (Nice) said it is "extremely disappointed" it will be unable to ...
SANFORD (WGME) -- A new warning letter from U.S. Food and Drug Administration (FDA) says some batches of Tom's of Maine ...
Therefore, incorporating cosmetic medicine as a part of employee benefit programs is attracting attention as an initiative ...
Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...
The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback